Biosurgical Agents | Market Insights | Asia Pacific (Supplemental) | 2018
The Asia Pacific market for biosurgical agents will grow moderately due to rising surgery volumes, which will drive unit sales; however, growing concerns over product cost and competition from local competitors will limit ASPs in this market to some extent.
This Medtech 360 Report provides high-level market metrics for surgical hemostats, internal tissue sealants, and adhesion barriers in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.
